Cargando…

Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophy

X-linked adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disease that results in the accumulation of very long chain fatty acids (VLCFA) in plasma and all tissues. Recent studies regarding cerebral X-ALD (CALD) treatment emphasize the importance of its early diagnosis. 26:0 lysophosphatid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chen, Iwamoto, Takeo, Igarashi, Junko, Miyajima, Takashi, Hossain, Mohammad Arif, Yanagisawa, Hiroko, Akiyama, Keiko, Shintaku, Haruo, Eto, Yoshikatsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506878/ https://www.ncbi.nlm.nih.gov/pubmed/28725571 http://dx.doi.org/10.1016/j.ymgmr.2017.06.004

Ejemplares similares

A combination of 7-ketocholesterol, lysosphingomyelin and bile acid-408 to diagnose Niemann-Pick disease type C using LC-MS/MS
por: Wu, Chen, et al.
Publicado: (2020)

Future clinical and biochemical predictions of Fabry disease in females by methylation studies of the GLA gene
por: Hossain, Mohammad Arif, et al.
Publicado: (2019)

Ten-year-long enzyme replacement therapy shows a poor effect in alleviating giant leg ulcers in a male with Fabry disease
por: Okada, Jun, et al.
Publicado: (2017)

A selective detection of lysophosphatidylcholine in dried blood spots for diagnosis of adrenoleukodystrophy by LC-MS/MS
por: Mashima, Ryuichi, et al.
Publicado: (2016)

Generation and characterization of motor neuron progenitors and motor neurons using metachromatic leukodystrophy-induced pluripotent stem cells
por: Hossain, Mohammad Arif, et al.
Publicado: (2022)

A neuropathological cell model derived from Niemann−Pick disease type C patient-specific iPSCs shows disruption of the p62/SQSTM1−KEAP1−NRF2 Axis and impaired formation of neuronal networks
por: Saito, Ryo, et al.
Publicado: (2021)

Newborn Screening for X-Linked Adrenoleukodystrophy
por: Moser, Ann B., et al.
Publicado: (2016)

Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme
por: Bessey, Alice, et al.
Publicado: (2018)

Sex‐specific newborn screening for X‐linked adrenoleukodystrophy
por: Albersen, Monique, et al.
Publicado: (2022)

Utility of measuring very long-chain fatty-acyl carnitines in dried blood spots for newborn screening of X-linked Adrenoleukodystrophy
por: Natarajan, Archana, et al.
Publicado: (2021)

Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor
por: Barendsen, Rinse W., et al.
Publicado: (2020)

Family Perspectives on Newborn Screening for X-Linked Adrenoleukodystrophy in California
por: Schwan, Katharina, et al.
Publicado: (2019)

Evaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina
por: Lee, Stacey, et al.
Publicado: (2020)

Newborn Screening for X-Linked Adrenoleukodystrophy: The Initial Illinois Experience
por: Burton, Barbara K., et al.
Publicado: (2022)

Newborn Screening for X-Linked Adrenoleukodystrophy: Past, Present, and Future
por: Moser, Ann B., et al.
Publicado: (2022)

Attitudes of Patients with Adrenoleukodystrophy towards Sex-Specific Newborn Screening
por: Yska, Hemmo A. F., et al.
Publicado: (2023)

Newborn Screening for X-Linked Adrenoleukodystrophy: Review of Data and Outcomes in Pennsylvania
por: Priestley, Jessica R. C., et al.
Publicado: (2022)

Corrigendum: Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor
por: Barendsen, Rinse W., et al.
Publicado: (2021)

Newborn Screening for X-Linked Adrenoleukodystrophy in Nebraska: Initial Experiences and Challenges
por: Baker, Craig V., et al.
Publicado: (2022)

L-leucine and SPNS1 coordinately ameliorate dysfunction of autophagy in mouse and human Niemann-Pick type C disease
por: Yanagisawa, Hiroko, et al.
Publicado: (2017)

A report on state‐wide implementation of newborn screening for X‐linked Adrenoleukodystrophy
por: Wiens, Katie, et al.
Publicado: (2019)

X‐linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies
por: Turk, Bela R., et al.
Publicado: (2020)

Advanced Diagnostic System and Introduction of Newborn Screening of Adrenoleukodystrophy and Peroxisomal Disorders in Japan
por: Shimozawa, Nobuyuki, et al.
Publicado: (2021)

Adrenoleukodystrophy Newborn Screening in California Since 2016: Programmatic Outcomes and Follow-Up
por: Matteson, Jamie, et al.
Publicado: (2021)

Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring
por: Bonaventura, Eleonora, et al.
Publicado: (2023)

Development, validation, and clinical application of an FIA‐MS/MS method for the quantification of lysophosphatidylcholines in dried blood spots
por: Yue, Xiaofei, et al.
Publicado: (2021)

Preventing Brain Damage from Hypoxic–Ischemic Encephalopathy in Neonates: Update on Mesenchymal Stromal Cells and Umbilical Cord Blood Cells
por: Nabetani, Makoto, et al.
Publicado: (2021)

Newborn Screening for X-Linked Adrenoleukodystrophy in Georgia: Experiences from a Pilot Study Screening of 51,081 Newborns
por: Hall, Patricia L., et al.
Publicado: (2020)

Childhood cerebral adrenoleukodystrophy
por: Mittal, Aliza, et al.
Publicado: (2014)

High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan
por: Chen, Hui-An, et al.
Publicado: (2022)

Diagnosing X-Linked Adrenoleukodystrophy after Implementation of Newborn Screening: A Reference Laboratory Perspective
por: Prinzi, Julia, et al.
Publicado: (2023)

C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man
por: van de Beek, Malu-Clair, et al.
Publicado: (2016)

Lysophosphatidylcholine Acyltransferase 3 Is the Key Enzyme for Incorporating Arachidonic Acid into Glycerophospholipids during Adipocyte Differentiation
por: Eto, Miki, et al.
Publicado: (2012)

Age and gender-specific reference intervals for a panel of lysophosphatidylcholines estimated by tandem mass spectrometry in dried blood spots
por: Natarajan, Archana, et al.
Publicado: (2022)

Bezafibrate for X-Linked Adrenoleukodystrophy
por: Engelen, Marc, et al.
Publicado: (2012)

Pathophysiology of X-linked adrenoleukodystrophy()
por: Berger, J., et al.
Publicado: (2014)

Multiple sclerosis in an adrenoleukodystrophy carrier
por: Jenkins, Thomas, et al.
Publicado: (2011)

Anesthesia in a child with adrenoleukodystrophy
por: Yang, Hun-Ju, et al.
Publicado: (2014)

Evolution of adrenoleukodystrophy model systems
por: Montoro, Roberto, et al.
Publicado: (2021)

Lysophosphatidylcholines and phosphatidylcholines as biomarkers for stroke recovery
por: Huang, Meiling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_32smhu6qf80egc0ch4cqrfequg